19 June 2013
Keywords: actilyse, gets, stroke, indication, eu, boehringer, ingelheim
Article | 03 February 2003
Boehringer Ingelheim's tissue plasminogen activator Actilyse(alteplase) has become the first drug to be approved in the European Union as ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.